Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy

IMPORTANCE: A decision to initiate aspirin therapy for primary prevention of cardiovascular disease (CVD) requires consideration of both treatment benefits and harms. The most significant harm associated with aspirin is major bleeding, yet there is a paucity of data on bleeding risk in suitable comm...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA
Главные авторы: Selak, Vanessa, Kerr, Andrew, Poppe, Katrina, Wu, Billy, Harwood, Matire, Grey, Corina, Jackson, Rod, Wells, Sue
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2018
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583689/
https://ncbi.nlm.nih.gov/pubmed/29946729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.8194
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы